OncoCyte: Q1 Earnings Snapshot

·1 min read

IRVINE, Calif. (AP) _ OncoCyte Corp. (OCX) on Monday reported a loss of $3.9 million in its first quarter.

The Irvine, California-based company said it had a loss of 5 cents per share. Losses, adjusted for non-recurring costs, were 4 cents per share.

The cancer diagnostic test developer posted revenue of $1.1 million in the period.

In the final minutes of trading on Monday, the company's shares hit $4.05. A year ago, they were trading at $2.88.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCX at https://www.zacks.com/ap/OCX

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting